Objectives To simplify our previous risk score for predicting the in-hospital mortality risk in patients with non-ST-segment elevation myocardial infarction (NSTEMI) by dropping laboratory data.
Design Prospective cohort.
Setting Multicentre, 108 hospitals across three levels in China.
Participants A total of 5775 patients with NSTEMI enrolled in the China Acute Myocardial Infarction (CAMI) registry.
Primary outcome measures In-hospital mortality.
Results The simplified CAMI-NSTEMI (SCAMI-NSTEMI) score includes the following nine variables: age, body mass index, systolic blood pressure, Killip classification, cardiac arrest, ST-segment depression on ECG, smoking status, previous angina and previous percutaneous coronary intervention. Within both the derivation and validation cohorts, the SCAMI-NSTEMI score showed a good discrimination ability (C-statistics: 0.76 and 0.83, respectively); further, the SCAMI-NSTEMI score had a diagnostic performance superior to that of the Global Registry of Acute Coronary Events risk score (C-statistics: 0.78 and 0.73, respectively; p<0.0001 for comparison). The in-hospital mortality increased significantly across the different risk groups.
Conclusions The SCAMI-NSTEMI score can serve as a useful tool facilitating rapid risk assessment among a broader spectrum of patients admitted owing to NSTEMI.
Trial registration number NCT01874691.
- updated risk score
- in-hospital mortality
This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
Statistics from Altmetric.com
Contributors RF and CS were major contributors in writing the manuscript. KD and YY contributed substantially to the conception and design of the study. YW, HX, XG revised it critically for important intellectual content. QL and CW contributed to data collection and follow up. SL, JL and JY made contribution to analysis and interpretation of data.
Funding This work was supported by CAMS Innovation Fund for Medical Sciences (CIFMS) (2016-I2M-1-009), the Twelfth Five-Year Planning Project of the Scientific and Technological Department of China (2011BAI11B02) and Fundamental Research Funds for the Central Universities (2018-F04).
Competing interests None declared.
Patient consent for publication Not required.
Ethics approval The China Acute Myocardial Infarction registry was approved by the Institutional Review Board Central Committee at Fuwai Hospital, Chinese Academy of Medical Sciences.
Provenance and peer review Not commissioned; externally peer reviewed.
Data availability statement Data are available upon reasonable request.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.